Rajagiri Hospital performs first liver transplant in India for rare disorder
Umar was suffering from Methylmalonic Acidemia (MMA) — a rare inherited metabolic disorder. Symptoms had started just three days after his birth, and Saniya, Umar's mother, visited several hospitals in New Delhi. The condition was finally diagnosed as MMA at AIIMS. Doctors concluded that a liver transplant was the only viable treatment. However, the facility did not have the infrastructure for the said paediatric liver condition. Considering the urgency, Dr Sharath R S, a pediatrician at AIIMS, posted an appeal from his account @tinyphysician on X seeking help.
Dr Cyriac Abby Philips from Rajagiri Hospital responded, stating that necessary medical infrastructure was available at the hospital and that financial assistance would also be provided. Saniya arrived at Rajagiri Hospital with her child on February 11.
Further tests revealed that Umar's liver function had severely deteriorated, necessitating an emergency transplant. A fully compatible donor could not be identified within the family. Saniya then asked whether her partially matched liver could be used to save her son's life. She volunteered, and the medical team offered their support.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
2 hours ago
- Time of India
AIIMS Nagpur, UNICEF to launch programme to address rising concerns of NCDs in children
Mumbai, The All India Institute of Medical Sciences (AIIMS) Nagpur and UNICEF Maharashtra have come together to tackle the growing risk of non-communicable diseases (NCDs) in children, which are under-recognised within the healthcare system and often undetected. According to the Comprehensive National Nutrition Survey 2019 , there is a growing risk of NCDs among children in the age group of 5 to 9 years and adolescents aged 10 to 19 years in India. The most common NCDs, such as obesity, asthma, diabetes, cancer, cardiovascular disease, and sickle cell disease, often originate from early-life risk factors, including poor nutrition, sedentary lifestyles, and environmental exposures. Talking to PTI, Dr Meenakshi Girish, head of the paediatrics department at AIIMS Nagpur , said, " Childhood NCDs are often under-recognised within the health system, leading to delayed diagnosis and management. In many cases, these conditions remain undetected until significant complications have already developed, which can result in long-term health consequences, reduced quality of life, and increased healthcare burden." The UNICEF, AIIMS Nagpur and the Maharashtra public health department have come together to address the rising challenge of NCDs among children. "The pilot of the programme is expected to be launched in September in Bhandara and Wardha in the Vidarbha region. We are working on designing the protocols and the training modules to ensure that the functionaries are well trained before the screening is rolled out," UNICEF Maharashtra Health Specialist Dr Mangesh Gadhari said. By the end of three years, the programme is expected to be introduced in 11 districts of Maharashtra. The task force for each NCD was formed in February, and in April, it got endorsement from the secretary of the public health department, he said. This NCD task force comprises experts from the Indian Academy of Paediatrics, government experts from medical colleges, academia and other professional associations. Since March, the department of paediatrics at AIIMS has operationalised an NCD clinic, which will be the Centre of Excellence (CoE) for childhood NCDs. Each day of the week is dedicated to a NCD condition, with experts and doctors working on early screening, management and awareness of these ailments. "This partnership merges the state government's unparalleled reach, UNICEF's advocacy, with AIIMS Nagpur's clinical expertise and research capabilities. Together, we're not simply treating individual cases, we are building a comprehensive, preventive ecosystem in the community that targets childhood obesity, diabetes, hypertension, and respiratory disorders at their roots," said Dr Prashant P Joshi, executive director of AIIMS Nagpur. By integrating joint community outreach programmes, capacity-building for healthcare workers, and robust data collection systems, through this programme, AIIMS aims to identify early-warning signs and intervene proactively, he said. "Our shared commitment to innovation and equity ensures that every child, regardless of their socio-economic background, has the chance to grow up healthy," Dr Joshi added.
Scroll.in
5 hours ago
- Scroll.in
AIIMS NORCET 9 registration deadline today; here's apply link
The All India Institute of Medical Sciences (AIIMS), New Delhi, will close the application window today, August 11, for the Nursing Officer Recruitment Common Eligibility Test 9 (NORCET 9). Eligible candidates can apply for the exam on the official website The stage 1 (Preliminary) exam will be conducted on September 14, and Mains will be held on September 27, 2025. Candidates can check the eligibility criteria, age limit, pay scale, and other details available in the notification below: Here's the official notification. Application Fee Candidates from the General/ OBC category are required to pay a fee of Rs 3000, whereas Rs 2400 applies to SC/ ST/ EWS candidates. Fee for PwD candidates are exempted from payment of the fee. Steps to register for AIIMS NORCET 9
Time of India
7 hours ago
- Time of India
AIIMS says commentary piece by researchers on e-cigarette ban doesn't represent its view
New Delhi: The AIIMS on Sunday clarified that a commentary piece by two of its researchers advocating a relook at India's ban on e-cigarettes is the authors' views and does not represent the institute's stance on the issue. "The AIIMS is in full support of the Government of India's ban on e-cigarettes under the Prohibition of Electronic Cigarettes Act, 2019," it said in a statement. As nicotine use among youth continues to rise as a potential threat in the country, AIIMS said that it strongly cautions against the deceptive advertisements of e-cigarettes under the garb of being a "safe alternative", particularly when it is being used in an unregulated or recreational setting. In response to media reports referencing an opinion on Electronic Nicotine Delivery Systems (ENDS), commonly known as e-cigarettes, AIIMS reiterated its clear and long-standing position opposing any form of tobacco and nicotine use, including e-cigarettes. The premier institute clarified that individual opinions and their conclusions are solely the responsibility of the respective principal investigators and research teams, and "do not represent the official stance or endorsement of AIIMS as an institution". The institute reaffirms its commitment to rigorous scientific standards, emphasising that only studies reviewed and formally adopted by its expert committees or management are considered the AIIMS' official position. The AIIMS consistently supports data-driven, evidence-based medical practice and policy and notes that any interpretation or unapproved communication should not be attributed to the institute as a whole, the statement said. It further stated that AIIMS has issued warnings against promoting, or even casually accepting, ENDS and e-cigarettes, especially among the youth. "The institute proudly stood in support of the Government of India's 2019 countrywide ban on ENDs, and will continue to stand for sound, scientific, and cautious public health policies," the statement said. AIIMS Director Dr M Srinivas has unequivocally stated in his address that the Institute is completely opposed to e-cigarettes He said, "AIIMS has always taken a clear stance against smoking and nicotine use, including e-cigarettes. We support prevention, regulation, and cessation, not replacement with unregulated alternatives." "Furthermore, official statements or policy communications are exclusively issued through designated AIIMS spokespersons or the administration. "AIIMS is committed to transparency and will continue to clarify its position when media or other entities misattribute findings to the institute," he said. The statement underlined that for authoritative information or clarification, one needs to refer to official notifications published on the AIIMS website or direct communication from authorised institutional representatives. It said that through the activities of its Tobacco Cessation Clinic (TCC), one of the first of its kind in India, AIIMS has led tobacco cessation initiatives in India. "The very existence and continuous working of this clinic speaks of AIIMS' unwavering dedication towards scaling down the burden of tobacco-related diseases in India," the statement added.>
